Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Leo Luznik
Modern Approaches to HLA-haploidentical Blood or Marrow Transplantation
Nature Reviews Clinical Oncology
Oncology
Multi-Institutional Study of Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Mechanism of Action of Posttransplantation Cyclophosphamide: More Than Meets the Eye
Journal of Clinical Investigation
Medicine
Targeting PI3Kδ Function for Amelioration of Murine Chronic Graft-Versus-Host Disease
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Comparable Composite Endpoints After HLA-matched and HLA-haploidentical Transplantation With Post-Transplantation Cyclophosphamide
Haematologica
Hematology
Regulatory T Cells Are Resistant to Cyclophosphamide (Cy) Through Expression of Aldehyde Dehydrogenase (ALDH) Upon Allogeneic Stimulation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Proteomic Biomarkers Are Predictive of Non-Relapse Mortality in Patients Treated With Post-Transplantation Cyclophosphamide Following HLA-Haploidentical or HLA-Matched-Related or –Unrelated Allogeneic BMT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Plasma-Derived Proteomic Biomarkers Have Prognostic Utility in Patients Treated With Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis for HLA-Matched Allogeneic Bone Marrow Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-Specific Anti-Hla Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Post Transplantation High-Dose Cyclophosphamide (PTCy) to Promote Immune Tolerance After Reconstructive Transplantation
Vascularized Composite Allotransplantation
1
2
›
